Phensuximide
- Level
- Commodity
- Parent
- 51141500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51141571This classification denotes an anticonvulsant agent with the molecular formula C11H11NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6WVL9C355G, chemically known as 2,5-pyrrolidinedione, 1-methyl-3-phenyl- but generally known as phensuximide, which bears US NIH Compound Identifier 6839. European Medicines Agency schedules Phensuximide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09783MIG. The term PHENSUXIMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules phensuximide in its Anatomical Therapeutic Chemical (ATC) Classification. PHENSUXIMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule phensuximide under HS 29251995 and SITC 51482. As of Q4 2014, PHENSUXIMIDE remains the US FDA Preferred Term for this commodity. Phensuximide bears US NLM identifiers UMLS ID C0070592 and NCI Concept Code C66375. SMILES: CN1C(=O)CC(C1=O)C2=CC=CC=C2.
Same parent
Under 51141500 · 80Activities that produce or sell this
KBLI · 8Inherited from family 51140000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.